From over 100,000 films, discover the handful you'll love.
Free or premium access to the world's largest documentary library.
17 films
Blood plasma has become a lucrative commodity in the U.S., with impoverished donors risking their health for income while pharmaceutical companies profit immensely.
Kip Andersen interviews health professionals and advocates to examine the health risks of meat and dairy consumption and the benefits of a plant-based diet.
One in five Americans takes a psychiatric drug, with pharmaceutical companies promoting benefits while downplaying risks and side effects.
Only 10% of patients seeking treatment at the Burzynski Clinic have access to the controversial Antineoplastons therapy currently in clinical trials.
Fetal stem cell injections have been administered to one in 15,000 people globally, prompting ethical debates about their use in medical treatments.
Brain doping, a trend among high achievers, involves the use of smart drugs that promise enhanced productivity and mental capabilities without the need for rest.
One in 15,000 people worldwide have received fetal stem cell treatments, which are legal and regulated only in Ukraine.
300 years is the potential prison sentence facing Dr. Stanislaw Brzezinski, who claims to have developed a breakthrough cancer treatment.
International patent regulations significantly impact developing countries, raising questions about their relevance in the context of a global knowledge economy.
Annual estimates indicate 35,000 deaths in the United States and 700,000 fatalities worldwide are linked to antibiotic-resistant bacteria.
Teen antidepressants are scrutinized for their questionable efficacy and the influence of corporate marketing, raising concerns about over-medication in youth.
The global plasma trade, driven by companies like Octafarma and CSL, exploits impoverished Americans who sell their blood for income, raising ethical concerns.
On March 13, 2006, eight healthy young men experienced severe health complications during a clinical trial for the experimental drug TGN1412.
The pharmaceutical industry is worth an estimated 1.42 trillion dollars, with many drugs derived from natural ingredients and indigenous knowledge.
In recent months, the price of some medications has shot up almost 5000%, raising concerns about access to life-saving drugs.
In 2005, six major pharmaceutical companies spent $20 billion on research and development but produced zero new FDA-approved drugs.
The number of compounds in the pharmaceutical industry's pipeline has increased compared to five years ago, according to Dan Vasella, CEO of Novartis.
